- Cash until Q1 2019 to run operations
- Restructure (30% decrease in cost savings), no cuts in sales staff mostly admin/management
- ~20% market share in Australia & moving to a distribution network
- Optimistic on sales uptake in the U.S moving forward with a new sales structure & tactics
- Surgeons are not as far along the adoption curve as anticipated
- Cash until Q1 2019 to run operations - Restructure (30%...
Add AXP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.824M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.1¢ | $3.052K | 1.651M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 43009120 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 90779583 | 59 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| AXP (ASX) Chart |
